CBER: Part 312 Subpart A - General Provisions; including applicability of requirements and requests for waivers

Investigational New Drug Regulations

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0014 can be found here:

Documents and Forms

Document Name Document Type
Form 1571 CBER: Part 312 Subpart A - General Provisions; including applicability of requirements and requests for waivers Form
1571 Investigational New Drug Application FORM FDA 1571 3-4-2015.pdf Form
1572 Statement of Investigator FORM FDA 1572 3-4-2015.pdf Form and Instruction

Information Collection (IC) Details

IC Title:	CBER: Part 312 Subpart A - General Provisions; including applicability of requirements and requests for waivers	Agency IC Tracking Number:

Is this a Common Form? No		IC Status: Unchanged

Obligation to Respond: Mandatory

CFR Citation: 21 CFR 312.1-312.10

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form	1571	Investigational New Drug Application	FORM FDA 1571 3-4-2015.pdf		Yes	Yes	Fillable Fileable Signable
Form and Instruction	1572	Statement of Investigator	FORM FDA 1572 3-4-2015.pdf		Yes	Yes	Fillable Fileable Signable

Line of Business: Health

Subfunction: Public Health Monitoring

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 239	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 0 %

	Approved	Previously Approved
Annual Number of Responses for this IC	287	287
Annual IC Time Burden (Hours)	7,608	7,608
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.